(DIR) Return Create A Forum - Home --------------------------------------------------------- MS Speaks (HTM) https://msspeaks.createaforum.com --------------------------------------------------------- ***************************************************** (DIR) Return to: GILENYA (fingolimod, FTY720) ***************************************************** #Post#: 3566-------------------------------------------------- More skin cancer reported to FDA from patients on certain oral D MTs By: agate Date: February 24, 2022, 8:23 pm --------------------------------------------------------- [font=verdana]From Multiple Sclerosis News Today (February 22, 2022)--"More Skin Cancer Reported to FDA from Patients on Certain Oral DMTs":[/font] [font=verdana] (HTM) https://bit.ly/3sgMJr6[/font] Mayzent (siponimod) and Gilenya (fingolimod) were the drugs where there was the most noticeable increase in skin cancer but several other MS drugs showed an increase as well. The article contains a statement that is worth noting: [quote]However, “evidence is insufficient to support a causative link,” the researchers wrote.[/quote] *****************************************************